FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [as printed] meets standards for safety and efficacy, March 1, 2005.

Bibliographic Details
Corporate Author: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Format: Government Document Book
Language:English
Published: Washington : U.S. G.P.O. : 2005.
Series:S. hrg. ; 109-67
Subjects:
Online Access:PDF version:
Description
Item Description:"Printed for the use of the Committee on Health, Education, Labor, and Pensions."
Shipping list number: 2005-0226-P.
Shipping list date: 09/07/2005
Distributed to some depository libraries in microfiche.
Physical Description:iii, 93 pages : illustrations ; 24 cm.
Also available via Internet from the GPO Access web site. Address as of 11/15/05: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=109_senate_hearings&docid=f:99761.wais (text version), http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=109%5Fsenate%5Fhearings&docid=f:99761.pdf (PDF version); current access is available via PURL.
Bibliography:Includes bibliographical references.
ISBN:0160726891